1. Home
  2. NKX vs BVS Comparison

NKX vs BVS Comparison

Compare NKX & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKX
  • BVS
  • Stock Information
  • Founded
  • NKX 2002
  • BVS 2011
  • Country
  • NKX United States
  • BVS United States
  • Employees
  • NKX N/A
  • BVS N/A
  • Industry
  • NKX Finance/Investors Services
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • NKX Finance
  • BVS Health Care
  • Exchange
  • NKX Nasdaq
  • BVS Nasdaq
  • Market Cap
  • NKX 581.2M
  • BVS 496.7M
  • IPO Year
  • NKX N/A
  • BVS 2021
  • Fundamental
  • Price
  • NKX $12.20
  • BVS $6.68
  • Analyst Decision
  • NKX
  • BVS Strong Buy
  • Analyst Count
  • NKX 0
  • BVS 4
  • Target Price
  • NKX N/A
  • BVS $15.00
  • AVG Volume (30 Days)
  • NKX 109.3K
  • BVS 445.3K
  • Earning Date
  • NKX 01-01-0001
  • BVS 05-06-2025
  • Dividend Yield
  • NKX 4.37%
  • BVS N/A
  • EPS Growth
  • NKX N/A
  • BVS N/A
  • EPS
  • NKX N/A
  • BVS N/A
  • Revenue
  • NKX N/A
  • BVS $567,699,000.00
  • Revenue This Year
  • NKX N/A
  • BVS N/A
  • Revenue Next Year
  • NKX N/A
  • BVS $6.09
  • P/E Ratio
  • NKX N/A
  • BVS N/A
  • Revenue Growth
  • NKX N/A
  • BVS 8.60
  • 52 Week Low
  • NKX $9.78
  • BVS $4.51
  • 52 Week High
  • NKX $12.00
  • BVS $14.38
  • Technical
  • Relative Strength Index (RSI)
  • NKX 52.34
  • BVS 35.26
  • Support Level
  • NKX $12.10
  • BVS $6.02
  • Resistance Level
  • NKX $12.23
  • BVS $7.07
  • Average True Range (ATR)
  • NKX 0.09
  • BVS 0.39
  • MACD
  • NKX 0.06
  • BVS -0.02
  • Stochastic Oscillator
  • NKX 92.86
  • BVS 33.67

About NKX Nuveen California AMT-Free Quality Municipal Income Fund

Nuveen California AMT-Free Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objectives are to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: